Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluvog M 500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Cista Medicorp

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Gluvog M 500mg/0.2mg Tablet SR

DiaBeta-Combo 500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Combo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, risking complications like kidney impairment, vision loss, neuropathy, and limb damage. DiaBeta-Combo is one component of a comprehensive diabetes management plan, also requiring a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Potential side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions, are usually transient. Persistent or concerning side effects necessitate medical consultation. Your doctor can offer strategies to mitigate or treat these effects. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require physician consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Gluvog M 500mg/0.2mg Tablet SR

There is no text provided to rewrite.

Uses of Gluvog M 500mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Gluvog M 500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Gluvog M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.

Common Side effects of Gluvog M 500mg/0.2mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Gluvog M 500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gluvog M 500mg/0.2mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.

How Gluvog M 500mg/0.2mg Tablet SR works:

Gluvog M 500mg/0.2mg extended-release tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gluvog M 500mg/0.2mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gluvog M 500mg/0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gluvog M 500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Gluvog M 500mg/0.2mg Extended-Release Tablets generally do not impair driving ability. Nevertheless, individuals taking this medication concurrently with other blood sugar-lowering drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Gluvog M 500mg/0.2mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Gluvog M 500mg/0.2mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Gluvog M 500mg/0.2mg sustained-release tablets to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Gluvog M 500mg/0.2mg Tablet SR :

Should you forget a Gluvog M 500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gluvog M 500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Gluvog M 500mg/0.2mg Tabl...
58
MRP 71
18% off